1-(8-(5)-ladderane-octanoyl)-2-(8-(3)-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol)

Metabolite details

Identifier

CNGMYZCFNFFBPY-JUUIFCSUSA-N

InChI Key

CNGMYZCFNFFBPY-JUUIFCSUSA-N

IUPAC name

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[8-(10-tetracyclo[6.4.0.02,7.03,6]dodecanyl)octoxy]propyl] 8-(4-pentacyclo[6.4.0.02,7.03,6.09,12]dodecanyl)octanoate

Preferred name

1-(8-(5)-ladderane-octanoyl)-2-(8-(3)-ladderane-octanyl)-sn-glycero-3-phospho-(1'-sn-glycerol)

INN name

—

Synonym

—

ChEBI

CHEBI:183189

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)

Observed in differential profiles

• WT_vs_WT_Aco
• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect